The FDA and the Federal Trade Commission (FTC) jointly launched the “Fraudulent STD Products Initiative.” This campaign targets over-the-counter (OTC) products sold online or in retail stores that claim to prevent, cure, or treat sexually transmitted diseases (STDs).
The FDA and the Federal Trade Commission (FTC) jointly launched the “Fraudulent STD Products Initiative.” This campaign targets over-the-counter (OTC) products sold online or in retail stores that claim to prevent, cure, or treat sexually transmitted diseases (STDs). At this time, there are no proven OTC or online products that treat or prevent STDs, nor has the FDA evaluated these products for safety and effectiveness (Table).1,2 The FDA and FTC believe these products may pose significant public health risk in that persons could be inaccurately treated, leading to delays in getting medical treatment and increasing the possibility of spreading disease to a sexual partner.1 The crux of the initiative is that only health care professionals can accurately diagnose and appropriately treat STDs.
Table. OTC Products Falsely Claiming to Treat or Prevent STDs
Manufacturer
Product Name
Immuneglory (Arenvy Laboratories, Inc)
ImmuneGlory
Viruxo
Viruxo
Masterpeace, Inc.
Disintegrate Formula, Echinacea/Golden Seal, Detox Formula, Burdock Extract
Int’l Inst of Holistic Health (doctorAJAdams)
Oil of Oregano P73 Physician’s Strength, Essaic Tonic Liquid Drops, Colloidal Silver 500ppm (Liquid)
PolyDNA
Gene-Eden
Pacific Naturals
Herpeset, Wartrol
Derma Remedies
H-Stop DX, H-Guard DX, Molluscum DX, Wart Dx
Flor Nutraceuticals
Herpaflor Outbreak Response Topical Liquid, Herpafl?r Outbreak Response Tablets, Herpaflor Outbreak Response Combo Pack, Herpaflor Daily Formula Tablets, Herpaflor Complete Package
Medavir
Medavir, ViraBalm, Vyristic Immune Support, Medavir H-Elimination Kit
Never An Outbreak
O2xygen Force (Oxygen Force/OxyForce), DMSO Cream, DMSO Roll-on, DMSO Cream with Aloe, AlkaLife
EverCLR3
EverCLR3
Chlamydia-Clinic.com
C-Cure
DMSO, dimethyl sulfoxide.
From FDA Web site. 2011.2
References
1. U.S. Food and Drug Administration. Fraudulent products: sexually transmitted diseases (STDs). Accessed May 15, 2011.
2. U.S. Food and Drug Administration. OTC products falsely claiming to treat or prevent STDs. Accessed May 14, 2011.
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Dostarlimab shows significant survival benefits in endometrial cancer trial
March 21st 2024GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.
Read More
Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening
February 21st 2024A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices.
Read More